Quick Takeaways
- Bryan Lawlis V has 3 issuer positions tracked on this page.
- Estimated disclosed ownership value: $3,209,700.
- Recent insider filing activity is available below.
Follow Filing Activity
Follow Bryan Lawlis V and return when a new Insider Trading filing changes the record on this page.
This uses the existing product follow flow to surface future filing-backed changes without guessing what they mean. If you create an account from here, we will bring you back after verification.
Insider ownership context is sourced from SEC Forms 3, 4, and 5.
| Symbol | Company | Relationship | Holdings Value | Past Year Net Change | Change % | Report Period |
|---|---|---|---|---|---|---|
| BMRN | BIOMARIN PHARMACEUTICAL INC | Director | $3,194,033 | 23 May 2023 | ||
| GERN | GERON CORP | Director | $15,667 | +$15,667 | +100% | 21 May 2025 |
| SYRE | Aeglea BioTherapeutics, Inc. | Director | 07 Jun 2022 |
| Sym | Company | Class | Transaction | % | Value $ | * Price $ | Shares | Shares After | Date | Ownership |
|---|